<DOC>
	<DOC>NCT00099749</DOC>
	<brief_summary>The efficacy and safety of FTY720 is being evaluated in patients who receive a kidney transplant.</brief_summary>
	<brief_title>Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant</brief_title>
	<detailed_description />
	<mesh_term>Fingolimod Hydrochloride</mesh_term>
	<criteria>Male and Female Between 18 to 65 years old Patients in need of multiple organ transplants</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Kidney, immunosuppression, transplant, rejection</keyword>
</DOC>